Genome-based prediction of common diseases: methodological considerations for future research
-
* Corresponding author: A Cecile JW Janssens a.janssens@erasmusmc.nl
Genome Medicine 2009, 1:20 doi:10.1186/gm20
Accesses
- Last 30 days: 120 accesses
- Last 365 days: 1076 accesses
- All time: 2890 accesses
Cited by
BioMed Central: 3 citations
|
Raluca Mihaescu, Ramal Moonesinghe, Muin J Khoury, A Janssens Genome Medicine 2011, 3:51 (28 July 2011) Analysis of the predictive ability of risk models to identify high-risk groups for complex diseases highlights the importance of the frequency of the risk group and the frequency of the disease.
|
|
Assessing the impact of a combined analysis of four common low-risk genetic variants on autism risk Jerome Carayol, Gerard D Schellenberg, Frederic Tores, Jörg Hager, Andreas Ziegler, Geraldine Dawson Molecular Autism 2010, 1:4 (22 February 2010) |
|
Genome-wide association studies in pharmacogenomics: untapped potential for translation Idris Guessous, Marta Gwinn, Muin J Khoury Genome Med 2009, 1:46 (28 April 2009) The integration of genome-wide association studies within the design of pharmacogenomics trials is currently underexploited but holds promise for accelerating the transfer of gene discoveries into clinical practice.
|